Bliss Kelly 4
4 · Teladoc Health, Inc. · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Teladoc (TDOC) President Bliss Kelly Sells 7,679 Shares
What Happened
Bliss Kelly, President, U.S. Group Health at Teladoc Health (TDOC), converted multiple performance/restricted stock unit awards into common shares on June 1, 2026, and then sold 7,679 shares in an open-market transaction on June 2, 2026 at $7.63 per share for total proceeds of $58,568. The Form 4 also reports conversion/exercise entries of 1,300, 4,858 and 9,152 shares on June 1 that are shown as disposals at $0 (see footnotes).
Key Details
- Transaction dates: June 1, 2026 (conversion/exercise of derivatives) and June 2, 2026 (open-market sale).
- Open-market sale: 7,679 shares @ $7.63 = $58,568.
- Conversions/exercises reported: 1,300; 4,858; 9,152 shares (each listed as acquired via derivative exercise on 6/1 and also listed as disposed at $0).
- Footnotes of note:
- F1/F2: Performance and restricted stock units convert 1:1 into common shares.
- F3: Shares were sold to cover tax withholding related to vesting.
- F4–F6: Detail prior PSU/RSU grants and vesting schedules relevant to these conversions.
- Shares owned after the transactions: not stated in the provided excerpt of the filing.
- Filing date: June 3, 2026 — filed within the normal Form 4 window (timely).
Context
The June 1 entries reflect conversion/vesting of equity awards (derivative exercises) rather than a cash purchase. The $0 disposals typically indicate shares withheld or transferred to cover tax withholding on vesting, per the footnotes; the separate June 2 sale was an open-market sale generating $58.6K. These items are routine insider transactions related to vesting and tax obligations rather than a straightforward buy signal.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-06-01+1,300→ 86,047 total - Exercise/Conversion
Common Stock
[F2]2026-06-01+4,858→ 90,905 total - Exercise/Conversion
Common Stock
[F2]2026-06-01+9,152→ 100,057 total - Sale
Common Stock
[F3]2026-06-02$7.63/sh−7,679$58,568→ 92,378 total - Exercise/Conversion
Performance Stock Units
[F1][F4]2026-06-01−1,300→ 9,098 total→ Common Stock (1,300 underlying) - Exercise/Conversion
Restricted Stock Units
[F2][F5]2026-06-01−4,858→ 14,577 total→ Common Stock (4,858 underlying) - Exercise/Conversion
Restricted Stock Units
[F2][F6]2026-06-01−9,152→ 64,070 total→ Common Stock (9,152 underlying)
Footnotes (6)
- [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F4]On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F5]On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
- [F6]On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.